Recorded Webinar with Dr. Curtis L. Cetrulo Sr.: Perinatal Stem Cells for Regenerative Medicine
Share the Science
Watch the recorded webinar to hear Dr. Curtis L. Cetrulo Sr., board-certified in OB/GYN and maternal medicine, and former professor at Tufts University School of Medicine, discuss maternal fetal medicine and the potential use of perinatal stem cells for the treatment of many diseases.
In the not too distant future, people who go to emergency rooms with chest pain, with the presumptive diagnosis of a heart attack, or myocardial infarction (MI), will be given an off-the-shelf stem cell preparation to prevent heart muscle damage. This stem cell product most likely will be a cocktail from a perinatal stem cell source—the placenta, cord blood, cord tissue, amniotic membrane and/or fluid. This webinar explores how we will get to that point and how these precious cells can be most efficiently collected, cryopreserved and stored.
You Will Learn:
- The sources of perinatal stem cells
- How early in pregnancy these cells are present
- The potential of perinatal stem cells for the treatment of many diseases
- The importance of saving the placenta, cord blood and cord tissue cells
Curtis L. Cetrulo Sr., M.D., discusses the importance of perinatal stem cells and the impact they will have on treating a variety of diseases.
Curtis L. Cetrulo, M.D., has a profound passion for stem cells and pursues this passion with the same excitement and energy that he has brought with him at every stage of his career. From 1984 until 2008, Dr. Cetrulo was a professor of obstetrics and gynecology at Tufts University School of Medicine. He is one of the two founding members of the International Cord Blood Society (ICBS), a non-profit organization founded in 1995 to promote cord blood research, and the nonprofit International Perinatal Stem Cell Society, Inc., formed in 2013.
Dr. Cetrulo is currently a board member and medical consultant for Auxocell Laboratories, Inc. He completed his obstetrics/gynecology residency program at the University of Colorado in Denver in 1973. Dr. Cetrulo graduated from the New Jersey College of Medicine in 1969. He did his undergraduate work at Columbia University (1965), where he was the captain of the 1964 NCAA champion fencing team.
Support the REGROW ACT
The REGROW ACT will open the door to one of the most exciting innovations in modern medicine for cellular therapy in the United States. REGROW allows for conditional approval after Phase I/Phase II safety and efficacy trials are complete.
To sign Perinatal Stem Cell Society’s petition urging the Senate to expedite passage of S. 2689, the REGROW ACT, go to https://www.change.org/p/congress-support-the-regrow-act.
Mediware and Save the Cord Foundation are proud to bring you this exclusive speaker series to discuss the topics you and your peers are most interested in. Join us as we feature your colleagues to discuss their latest research, opinions on industry news and so much more. We look forward to having you on board for this exciting series!